Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): Recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 59, Issue 230, 1999, Pages 103-112

  Panteghini, Mauro ^a   Apple, Fred S ^b   Christenson, Robert H ^c   Dati, Francesco ^d   Mair, Johannes ^e   Wu, Alan H ^f  

^a SPEDALI CIVILI   (Italy)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^d DiaSys Diagnostic Systems   (Germany)

^e UNIVERSITY OF INNSBRUCK   (Austria)

^f HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ELECTROCARDIOGRAPHY; HEART INJURY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; STANDARDIZATION; THORAX PAIN; ACUTE DISEASE; BLOOD; CLINICAL CHEMISTRY; CONSENSUS DEVELOPMENT; CORONARY ARTERY DISEASE; HEART MUSCLE; PATHOLOGY; STANDARD;

ACUTE DISEASE; BIOLOGICAL MARKERS; CHEMISTRY, CLINICAL; CORONARY DISEASE; HUMANS; MYOCARDIUM; REFERENCE STANDARDS;

EID: 0033003236     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519909168333     Document Type: Conference Paper

References (48)

1. Bhayana V, Henderson AR. Biochemical markers of myocardial damage. Clin Biochem 1995;28:1-29.
2. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979;59:607-9.
3. Hlatky MA. Evaluation of chest pain in the emergency department. N Engl J Med 1997; 337:1687-9.
4. The Cardiology Roundtable. Perfecting MI Ruleout. Best Practices for Emergency Evaluation of Chest Pain. The Advisory Board Company, 1994.
5. Lee TH, Rouan GW, Weisberg MC, Brand DA, Acampora D, Stasiulewicz C, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 1987;60:219-24.
6. McCarthy B, Beshansky JR, D'Agostino RB, Selker HP. Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med 1993;22:579-82.
7. Panteghini M, Pagani F. Diagnostic value of a single measurement of troponin T in serum for suspected acute myocardial infarction. Clin Chem 1994;40:673-4.
8. Adams JE III, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s ? Circulation 1993;88:750-63.
9. De Winter RJ, Koster RW, Sturk A, Sanders GT. Value of myoglobin, troponin T. and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995;92:3401-7.
10. Panteghini M, Altinier S, Dolci A, Pagani F, Pergolini P, Vernocchi A, Zaninotto M. Multicenter evaluation of five methods for myoglobin determination. Clin Chem 1998;44(suppl):A121.
11. Puleo PR, Meyer D, Wathen C, Tawa C, Wheeler S, Hamburg RJ, et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994;331:561-6.
12. Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995;41:966-78.
13. Glatz JFC, van der Vusse GJ, Simoons ML, Kragten JA, van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998;272:87-92.
14. Adams JE III, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993;88:101-6.
15. Lavoinne A, Hue G. Serum cardiac troponin I and T in early posttraumatic rhabdomyolysis. Clin Chem 1998;44:667-8.
16. Montague C, Kircher T. Myoglobin in the early evaluation of acute chest pain. Am J Clin Pathol 1995;104:472-6.
17. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
18. The Thrombolysis in Myocardial Infarction (TIMI) Study Group. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 1985;312:932-6.
19. The GISSI Study Group. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
20. Rouan GW, Lee TH, Cook EF, Brand DA, Weisberg MC, Goldman L. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (A report from the Multicenter Chest Pain Study). Am J Cardiol 1989;64:1087-92.
21. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part I. N Engl J Med 1992;326:242-50.
22. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part II. N Engl J Med 1992;326:310-8.
23. Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651-7.
24. Luscher MS, Thygesen K, Ravkilde J, Heickendorff L, for the TRIM Study Group. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997;96:2578-85.
25. Solberg HE. IFCC approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987;25:645-56.
26. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
27. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. Br Med J 1996;313:262-4.
28. Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Troponin T indentifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997;29:43-8.
29. Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997;95:2053-9.
30. Ryan TJ, Andersen JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28:1328-428.
31. Kwong TC, Fitzpatrick PG, Rothbard RL. Activities of some enzymes in serum after therapy with intracoronary streptokinase in acute mycardial infarction. Clin Chem 1984;30:731-4.
32. Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993;87:1542-50.
33. Apple FS, Henry TD, Berger CR, Landt YA. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Pathol 1996;105:6-10.
34. Hohnloser SH, Zabel M, Kasper W, Meinertz T, Just H. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991;18:44-9.
35. Baskin JM, Wilkins ML, Ohman EM, Clemmensen P, grande P, Christenson RH, et al. Ratio of ST-segment and myoglobin slopes to estimate myocardial savage during thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1993;71:1362-5.
36. Christenson RH, Ohman EM, Topol EJ, Peck S, Newby LK, Duh SH, et al. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. Circulation 1997;96:1776-82.
37. Lee TH, Thomas EJ, Ludwig LE, Sacks DB, Johnson PA, Donaldson MC, et al. Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery. Am J Cardiol 1996;77:1031-6.
38. Anderson FP, Jesse RL, Nicholson CS, Miller WG. The costs and effectiveness of a rapid diagnostic and treatment protocol for myocardial infarction. In: Bowie LJ, editor. Assessing clinical outcomes. Utilizing appropriate laboratory testing to decrease the healthcare costs and improve patient outcomes. Washington DC: AACC Leadership Series, 1996:20-4.
39. Wu AHB. Use of cardiac markers as assessed by outcome analysis. Clin Biochem 1997;30:339-50.
40. Panteghini M. IFCC Committee on standardization of markers of cardiac damage: premises and project presentation. Clin Chem Lab Med 1998;36:887-93.
41. Panteghini M, Cuccia C, Pagani F, Turla C. Comparison of the diagnostic performance of two rapid bedside biochemical assays in the early detection of acute myocardial infarction. Clin Cardiol 1998;21:394-8.
42. Heeschen C, Goldman BU, Moeller RH, Hamm CW. Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I. Clin Chem 1998;44:1925-30
43. Gerhardt W, Ljungdahl L, Collinson PO, Lovis C, Mach F, Sylven C, et al. An improved rapid troponin T test with a decreased detection limit: a multicentre study of the analytical and clinical performance in suspected myocardial damage. Scand J Clin Lab Invest 1997;57:549-58.
44. Apple FS, Christenson RH, Valdes R, Andriak AJ, Berg A, Duh SH, et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB. and cardiac troponin I by the Triage Cardiac Panel for detection of myocardial infarction. Clin Chem 1999;45:199-205.
45. Henderson AR, Krishnan S, Webb S, Cheung CM, Nazir DJ, Richardson H. Proficiency testing of creatine kinase and creatine kinase-2: the experience of the Ontario Laboratory Proficiency Testing Program. Clin Chem 1998;44:124-33.
46. Wu AHB, Feng YJ, Moore R, Apple FS, McPherson PH; Buechler KF, Bodor G, for the AACC Subcommittee on cTnI standardization. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998;44:1198-208.
47. Panteghini M, Pagani F. Biological variation of myoglobin in serum. Clin Chem 1997;43:2435.
48. Ross SM, Fraser CG. Biological variation of cardiac markers: analytical and clinical considerations. Ann Clin Biochem 1998;35:80-4.